Proteomic profiling reveals comprehensive insights into adrenergic receptor-mediated hypertrophy in neonatal rat cardiomyocytes

Proteomics - Clinical Applications

Volumn 3, Issue 12, 2009, Pages 1407-1421

  Li, Zijian ^a   Liu, Ning ^b,c   Zhang, Li Shu ^d   Gong, Kaizheng ^a   Cai, Yuanbin ^a   Gao, Wei ^a   Liu, Zhiqiang ^c   Liu, Shuying ^c   Han, Qide ^a   Zhang, Youyi ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b JILIN UNIVERSITY   (China)

^c CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adrenergic receptor; Cardiac hypertrophy

Indexed keywords

ADRENERGIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MITOCHONDRIAL RESPIRATION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

RATTUS;

EID: 77951083378     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900029     Document Type: Article

References (48)

1. Cabassi, A., Dancelli, S., Pattoneri, P., Tirabassi, G. et al., Characterization of myocardial hypertrophy in prehypertensive spontaneously hypertensive rats: interaction between adrenergic and nitrosative pathways. J. Hypertens. 2007, 25, 1719-1730.
2. Varma, D. R., Deng, X. F., Cardiovascular alpha1-adreno-ceptor subtypes: functions and signaling. Can. J. Physiol. Pharmacol. 2000, 78, 267-292.
3. Koch, W. J., Lefkowitz, R. J., Rockman, H. A., Functional consequences of altering myocardial adrenergic receptor signaling. Annu. Rev. Physiol. 2000, 62, 237-260.
4. Nienaber, J. J., Tachibana, H., Naga Prasad, S. V., Esposito, G. et al., Inhibition of receptor-localized PI3K preserves cardiac beta adrenergic receptor function and ameliorates pressure overload heart failure. J. Clin. Invest. 2003, 112, 1067-1079.
5. Ramirez, M. T., Sah, V. P., Zhao, X. L., Hunter, J. J. et al., The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J. Biol. Chem. 1997, 272, 14057-14061.
6. Pandi-Perumal, S. R., Trakht, I., Srinivasan, V., Spence, D. W. et al., Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways. Prog. Neurobiol. 2008, 85, 335-353.
7. Karmazyn, M., Purdham, D. M., Rajapurohitam, V., Zeidan, A., Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc. Res. 2008, 79, 279-286.
8. Barry, S. P., Davidson, S. M., Townsend, P. A., Molecular regulation of cardiac hypertrophy. Int. J. Biochem. Cell Biol. 2008, 40, 2023-2039.
9. Sucharov, C. C., Beta-adrenergic pathways in human heart failure. Expert. Rev. Cardiovasc. Ther. 2007, 5, 119-124.
10. Gramolini, A. O., Kislinger, T., Alikhani-Koopaei, R., Fong, V. et al., Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol. Cell. Proteomics 2008, 7, 519-533.
11. Gerszten, R. E., Wang, T. J., The search for new cardiovascular biomarkers. Nature 2008, 451, 949-952.
12. Raddatz, K., Albrecht, D., Hochgrafe, F., Hecker, M., Gotthardt, M., A proteome map of murine heart and skeletal muscle. Proteomics 2008, 8, 1885-1897.
13. Calvano, S. E., Xiao, W., Richards, D. R., Felciano, R. M. et al., Inflamm and host response to injury large scale collab. res. program. A network-based analysis of systemic inflammation in humans. Nature 2005, 437, 1032-1037.
14. Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V. et al., Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006, 443, 578-581.
15. Yamada, K., Gerber, D. J., Iwayama, Y., Ohnishi, T. et al., Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc. Natl. Acad. Sci. USA 2007, 104, 2815-2820.
16. Barceló-Batllori, S., Kalko, S. G., Esteban, Y., Moreno, S. et al., Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue. Mol. Cell. Proteomics 2008, 7, 378-393.
17. Hanada, K., Vermeij, M., Garinis, G. A., de Waard, M. C. et al., Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice. Circ. Res. 2007, 100, 738-746.
18. Amatschek, S., Kriehuber, E., Bauer, W., Reininger, B. et al., Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. Blood 2007, 109, 4777-4785.
19. Scheuer, J., Catecholamines in cardiac hypertrophy. Am. J. Cardiol. 1999, 83, 70-74.
20. Simpson, P., Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an a1-adrenergic response. J. Clin. Invest. 1983, 72, 732-738.
21. Simpson, P., McGrath, A., Savion, S., Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ. Res. 1982, 51, 787-801.
22. Deng, X. F., Rokosh, D. G., Simpson, P. C., Autonomous and Growth Factor-Induced Hypertrophy in Cultured Neonatal Mouse Cardiac Myocytes. Circ. Res. 2000, 87, 781-788.
23. Simpson, P., Stimulation of hypertrophy of cultured neonatal rat heart cells through an a1-adrenergic receptor and induction of beating through an α1-and β1-adrenergic receptor interaction: evidence for independent regulation of growth and beating. Circ. Res. 1985, 56, 884-894.
24. Ito, H., Hirata, Y., Hiroe, M., Tsujino, M. et al., Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ. Res. 1991, 69, 209-215.
25. Bogoyevitch, M. A., Andersson, M. B., Gillespie-Brown, J., Clerk, A. et al., Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem. J. 1996, 314, 115-121.
26. Sadoshima, J., Jahn, L., Takahashi, T., Kulik, T. J., Izumo, S., Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J. Biol. Chem. 1992, 267, 10551-10560.
27. Zhang, Y., Yan, J., Chen, K., Song, Y. et al., Different roles of a1-adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats. Clin. Exp. Pharmacol. Physiol. 2004, 31, 626-633.
28. Gonzalez, A. M., Osorio, J. C., Manlhiot, C., Gruber, D. et al., Hypertrophy signaling during peripartum cardiac remodeling. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, 3008-3013.
29. Tutor, A. S., Penela, P., Mayor, F., Jr., Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells. Cardiovasc. Res. 2007, 76, 51-60.
30. Fischer, P., Hilfiker-Kleiner,D., Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res. Cardiol. 2007, 102, 279-297.
31. Yang, L., Zou, X., Liang, Q., Chen, H. et al., Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway. Exp. Mol. Med. 2007, 39, 65-73.
32. Maynard, S. J., Menown, I. B., Adgey, A. A., Troponin T and I as cardiac markers in ischaemic heart disease. Heart 2000, 83, 371-373.
33. Conway, B., McLaughlin, M., Sharpe, P., Harty, J., Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis. Nephrol. Dial. Transplant. 2005, 20, 2759-2764.
34. Jäger, D., Jungblut, P. R., Muller-Werdan, U., Separation and identification of human heart proteins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 771, 131-153.
35. Arnott, D., O'Connell, K. L., King, K. L., Stults, J. T., An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. Anal. Biochem. 1998, 258, 1-18.
36. Lindsey, M. L., Goshorn, D. K., Comte-Walters, S., Hendrick, J. W. et al., A multidimensional proteomic approach to identify hypertrophy-associated proteins. Proteomics 2006, 6, 2225-2235.
37. Dzeja, P. P., Redfield, M. M., Burnett, J. C., Terzic, A., Failing energetics in failing hearts. Curr. Cardiol. Rep. 2000, 3, 212-217.
38. Koyama, H., Shoji, T., Fukumoto, S., Shinohara, K. et al., Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 147-153.
39. Silver, A. E., Beske, S. D., Christou, D. D., Donato, A. J. et al., Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47phox expression and evidence of endothelial oxidative stress. Circulation 2007, 115, 627-637.
40. Hirono, Y., Yoshimoto, T., Suzuki, N., Sugiyama, T. et al., Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system. Endocrinology 2007, 148, 1688-1696.
41. Seddon, M., Looi, Y. H., Shah, A. M., Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007, 93, 903-907.
42. Murdoch, C. E., Zhang, M., Cave, A. C., Shah, A. M., NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc. Res. 2006, 71, 208-215.
43. Frantz, S., Brandes, R. P., Hu, K., Rammelt, K. et al., Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX. Basic Res. Cardiol. 2006, 101, 127-132.
44. Harrison, D. G., Cai, H., Landmesser, U., Griendling, K. K., Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J. Renin. Angiotensin. Aldosterone. Syst. 2003, 4, 51-61.
45. Xiang, Y., Kobilka, B. K., Myocyte adrenoceptor signaling pathways. Science 2003, 300, 1530-1532.
46. O'Connell, T. D., Ishizaka, S., Nakamura, A., Swigart, P. M. et al., The alpha (1A/C)-and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J. Clin. Invest. 2003, 111, 1783-1791.
47. O'Connell, T. D., Swigart, P. M., Rodrigo, M. C., Ishizaka, S. et al., Alpha1 adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J. Clin. Invest. 2006, 116, 1005-1015.
48. Li, N., Ragheb, K., Lawler, G., Sturgis, J. et al., DPI induces mitochondrial superoxide-mediated apoptosis. Free Radic. Biol. Med. 2003, 34, 465-477.